Rachel Upthegrove
MBE, MBBS, FRCPsych, PhD
Professor of Psychiatry, Director Designate NIHR Oxford Health Biomedical Research Centre
- Chair NIHR Mental Health Translational Research Collaboration (MH-TRC)
- Co-lead Early Psychosis, Molecular Targets BRC Theme
- Professor of Psychiatry and Youth Mental Health, Institute for Mental Health, University of Birmingham
- Honorary Consultant Psychiatrist, Early Intervention in Psychosis
- Honorary General Secretary, British Association for Psychopharmacology
Early Psychosis, Severe Mental Illness, Immunopsychiatry, Multimorbidity
Rachel trained in Medicine at the Royal Free Hospital, University of London and completed her PhD at the University of Birmingham, investigating depression and suicidality in first episode psychosis. Her research focuses on the identification of novel treatments for early stages of severe mental illness with focus on co-morbidity.
She leads the Psychosis Immune Mechanism Stratified Medicine Study (PIMS), a collaborative multi-stage project investigating inflammatory mechanisms and phenotypic profile of psychosis. PIMS is currently completing a targeted trial of Tocilizumab in patients with early psychosis and evidence of immune activation.
Rachel is chief investigator and co-investigator on a number of NIHR funded trials for repurposed and targeted treatments, including the NIHR HTA ADEPP study (Antidepressants for the prevention of depression following first episode psychosis).
Her translational research includes NIHR funded Early Psychosis Informatics into Care (EPICare), a collaborative project developing a national digital registry and clinical decision support system for patients and clinicians in early intervention services.
Recent publications
-
Journal article
Lee R. et al, (2024), Schizophrenia Research, 274, 66 - 77
-
Journal article
Lalousis PA. et al, (2024), Biological Psychiatry, 96, 615 - 622
-
Journal article
Wood GK. et al, (2024), Nat Med
-
Journal article
Altaweel N. et al, (2024), J Affect Disord, 367, 157 - 163
-
Journal article
Metry Y. et al, (2024), BMJ open, 14
-
Journal article
Dunleavy C. et al, (2024), Brain, Behavior, and Immunity, 120, 379 - 390
-
Preprint
MacPhee M. et al, (2024)
-
Journal article
Wykes T. et al, (2024), Programme Grants for Applied Research, 12
-
Journal article
Upthegrove R. and Goldsmith DR., (2024), Brain, Behavior, and Immunity, 119, 709 - 712
-
Journal article
Worrell C. et al, (2024), BMJ Open, 14